Report Cover

Global Human Immune Globulin Intravenous Market Insights and Forecast to 2026


Human Immune Globulin Intravenous market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Immune Globulin Intravenous market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Immune Globulin Intravenous market is segmented into
    IVIg Liquid
    IVIg Powder

Segment by Application, the Human Immune Globulin Intravenous market is segmented into
    Immunodeficiency
    Autoimmune Disease
    Acute Infection

Regional and Country-level Analysis
The Human Immune Globulin Intravenous market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Immune Globulin Intravenous market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Immune Globulin Intravenous Market Share Analysis
Human Immune Globulin Intravenous market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Immune Globulin Intravenous business, the date to enter into the Human Immune Globulin Intravenous market, Human Immune Globulin Intravenous product introduction, recent developments, etc.

The major vendors covered:
    Baxter
    Grifols
    CSL
    Octapharma
    Biotest
    Kedrion
    Hualan Bio
    CNBG
    Shanghai RAAS
    CBPO
    LFB Group
    BPL
    Sichuan Yuanda Shuyang
1 Study Coverage
    1.1 Human Immune Globulin Intravenous Product Introduction
    1.2 Market Segments
    1.3 Key Human Immune Globulin Intravenous Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Human Immune Globulin Intravenous Market Size Growth Rate by Type
        1.4.2 IVIg Liquid
        1.4.3 IVIg Powder
    1.5 Market by Application
        1.5.1 Global Human Immune Globulin Intravenous Market Size Growth Rate by Application
        1.5.2 Immunodeficiency
        1.5.3 Autoimmune Disease
        1.5.4 Acute Infection
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Human Immune Globulin Intravenous Market Size, Estimates and Forecasts
        2.1.1 Global Human Immune Globulin Intravenous Revenue 2015-2026
        2.1.2 Global Human Immune Globulin Intravenous Sales 2015-2026
    2.2 Global Human Immune Globulin Intravenous, Market Size by Producing Regions: 2015 VS 2020 VS 2026
        2.2.1 Global Human Immune Globulin Intravenous Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Human Immune Globulin Intravenous Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Immune Globulin Intravenous Competitor Landscape by Players
    3.1 Human Immune Globulin Intravenous Sales by Manufacturers
        3.1.1 Human Immune Globulin Intravenous Sales by Manufacturers (2015-2020)
        3.1.2 Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2015-2020)
    3.2 Human Immune Globulin Intravenous Revenue by Manufacturers
        3.2.1 Human Immune Globulin Intravenous Revenue by Manufacturers (2015-2020)
        3.2.2 Human Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Human Immune Globulin Intravenous Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Human Immune Globulin Intravenous Revenue in 2019
        3.2.5 Global Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Human Immune Globulin Intravenous Price by Manufacturers
    3.4 Human Immune Globulin Intravenous Manufacturing Base Distribution, Product Types
        3.4.1 Human Immune Globulin Intravenous Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Human Immune Globulin Intravenous Product Type
        3.4.3 Date of International Manufacturers Enter into Human Immune Globulin Intravenous Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Human Immune Globulin Intravenous Market Size by Type (2015-2020)
        4.1.1 Global Human Immune Globulin Intravenous Sales by Type (2015-2020)
        4.1.2 Global Human Immune Globulin Intravenous Revenue by Type (2015-2020)
        4.1.3 Human Immune Globulin Intravenous Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Human Immune Globulin Intravenous Market Size Forecast by Type (2021-2026)
        4.2.1 Global Human Immune Globulin Intravenous Sales Forecast by Type (2021-2026)
        4.2.2 Global Human Immune Globulin Intravenous Revenue Forecast by Type (2021-2026)
        4.2.3 Human Immune Globulin Intravenous Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Human Immune Globulin Intravenous Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Human Immune Globulin Intravenous Market Size by Application (2015-2020)
        5.1.1 Global Human Immune Globulin Intravenous Sales by Application (2015-2020)
        5.1.2 Global Human Immune Globulin Intravenous Revenue by Application (2015-2020)
        5.1.3 Human Immune Globulin Intravenous Price by Application (2015-2020)
    5.2 Human Immune Globulin Intravenous Market Size Forecast by Application (2021-2026)
        5.2.1 Global Human Immune Globulin Intravenous Sales Forecast by Application (2021-2026)
        5.2.2 Global Human Immune Globulin Intravenous Revenue Forecast by Application (2021-2026)
        5.2.3 Global Human Immune Globulin Intravenous Price Forecast by Application (2021-2026)

6 North America
    6.1 North America Human Immune Globulin Intravenous by Country
        6.1.1 North America Human Immune Globulin Intravenous Sales by Country
        6.1.2 North America Human Immune Globulin Intravenous Revenue by Country
        6.1.3 U.S.
        6.1.4 Canada
    6.2 North America Human Immune Globulin Intravenous Market Facts & Figures by Type
    6.3 North America Human Immune Globulin Intravenous Market Facts & Figures by Application

7 Europe
    7.1 Europe Human Immune Globulin Intravenous by Country
        7.1.1 Europe Human Immune Globulin Intravenous Sales by Country
        7.1.2 Europe Human Immune Globulin Intravenous Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 U.K.
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Human Immune Globulin Intravenous Market Facts & Figures by Type
    7.3 Europe Human Immune Globulin Intravenous Market Facts & Figures by Application

8 Asia Pacific
    8.1 Asia Pacific Human Immune Globulin Intravenous by Region
        8.1.1 Asia Pacific Human Immune Globulin Intravenous Sales by Region
        8.1.2 Asia Pacific Human Immune Globulin Intravenous Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Taiwan
        8.1.9 Indonesia
        8.1.10 Thailand
        8.1.11 Malaysia
        8.1.12 Philippines
        8.1.13 Vietnam
    8.2 Asia Pacific Human Immune Globulin Intravenous Market Facts & Figures by Type
    8.3 Asia Pacific Human Immune Globulin Intravenous Market Facts & Figures by Application

9 Latin America
    9.1 Latin America Human Immune Globulin Intravenous by Country
        9.1.1 Latin America Human Immune Globulin Intravenous Sales by Country
        9.1.2 Latin America Human Immune Globulin Intravenous Revenue by Country
        9.1.3 Mexico
        9.1.4 Brazil
        9.1.5 Argentina
    9.2 Central & South America Human Immune Globulin Intravenous Market Facts & Figures by Type
    9.3 Central & South America Human Immune Globulin Intravenous Market Facts & Figures by Application

10 Middle East and Africa
    10.1 Middle East and Africa Human Immune Globulin Intravenous by Country
        10.1.1 Middle East and Africa Human Immune Globulin Intravenous Sales by Country
        10.1.2 Middle East and Africa Human Immune Globulin Intravenous Revenue by Country
        10.1.3 Turkey
        10.1.4 Saudi Arabia
        10.1.5 U.A.E
    10.2 Middle East and Africa Human Immune Globulin Intravenous Market Facts & Figures by Type
    10.3 Middle East and Africa Human Immune Globulin Intravenous Market Facts & Figures by Application

11 Company Profiles
    11.1 Baxter
        11.1.1 Baxter Corporation Information
        11.1.2 Baxter Description and Business Overview
        11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Baxter Human Immune Globulin Intravenous Products Offered
        11.1.5 Baxter Related Developments
    11.2 Grifols
        11.2.1 Grifols Corporation Information
        11.2.2 Grifols Description and Business Overview
        11.2.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 Grifols Human Immune Globulin Intravenous Products Offered
        11.2.5 Grifols Related Developments
    11.3 CSL
        11.3.1 CSL Corporation Information
        11.3.2 CSL Description and Business Overview
        11.3.3 CSL Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 CSL Human Immune Globulin Intravenous Products Offered
        11.3.5 CSL Related Developments
    11.4 Octapharma
        11.4.1 Octapharma Corporation Information
        11.4.2 Octapharma Description and Business Overview
        11.4.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Octapharma Human Immune Globulin Intravenous Products Offered
        11.4.5 Octapharma Related Developments
    11.5 Biotest
        11.5.1 Biotest Corporation Information
        11.5.2 Biotest Description and Business Overview
        11.5.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 Biotest Human Immune Globulin Intravenous Products Offered
        11.5.5 Biotest Related Developments
    11.6 Kedrion
        11.6.1 Kedrion Corporation Information
        11.6.2 Kedrion Description and Business Overview
        11.6.3 Kedrion Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 Kedrion Human Immune Globulin Intravenous Products Offered
        11.6.5 Kedrion Related Developments
    11.7 Hualan Bio
        11.7.1 Hualan Bio Corporation Information
        11.7.2 Hualan Bio Description and Business Overview
        11.7.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 Hualan Bio Human Immune Globulin Intravenous Products Offered
        11.7.5 Hualan Bio Related Developments
    11.8 CNBG
        11.8.1 CNBG Corporation Information
        11.8.2 CNBG Description and Business Overview
        11.8.3 CNBG Sales, Revenue and Gross Margin (2015-2020)
        11.8.4 CNBG Human Immune Globulin Intravenous Products Offered
        11.8.5 CNBG Related Developments
    11.9 Shanghai RAAS
        11.9.1 Shanghai RAAS Corporation Information
        11.9.2 Shanghai RAAS Description and Business Overview
        11.9.3 Shanghai RAAS Sales, Revenue and Gross Margin (2015-2020)
        11.9.4 Shanghai RAAS Human Immune Globulin Intravenous Products Offered
        11.9.5 Shanghai RAAS Related Developments
    11.10 CBPO
        11.10.1 CBPO Corporation Information
        11.10.2 CBPO Description and Business Overview
        11.10.3 CBPO Sales, Revenue and Gross Margin (2015-2020)
        11.10.4 CBPO Human Immune Globulin Intravenous Products Offered
        11.10.5 CBPO Related Developments
    11.1 Baxter
        11.1.1 Baxter Corporation Information
        11.1.2 Baxter Description and Business Overview
        11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Baxter Human Immune Globulin Intravenous Products Offered
        11.1.5 Baxter Related Developments
    11.12 BPL
        11.12.1 BPL Corporation Information
        11.12.2 BPL Description and Business Overview
        11.12.3 BPL Sales, Revenue and Gross Margin (2015-2020)
        11.12.4 BPL Products Offered
        11.12.5 BPL Related Developments
    11.13 Sichuan Yuanda Shuyang
        11.13.1 Sichuan Yuanda Shuyang Corporation Information
        11.13.2 Sichuan Yuanda Shuyang Description and Business Overview
        11.13.3 Sichuan Yuanda Shuyang Sales, Revenue and Gross Margin (2015-2020)
        11.13.4 Sichuan Yuanda Shuyang Products Offered
        11.13.5 Sichuan Yuanda Shuyang Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Human Immune Globulin Intravenous Market Estimates and Projections by Region
        12.1.1 Global Human Immune Globulin Intravenous Sales Forecast by Regions 2021-2026
        12.1.2 Global Human Immune Globulin Intravenous Revenue Forecast by Regions 2021-2026
    12.2 North America Human Immune Globulin Intravenous Market Size Forecast (2021-2026)
        12.2.1 North America: Human Immune Globulin Intravenous Sales Forecast (2021-2026)
        12.2.2 North America: Human Immune Globulin Intravenous Revenue Forecast (2021-2026)
        12.2.3 North America: Human Immune Globulin Intravenous Market Size Forecast by Country (2021-2026)
    12.3 Europe Human Immune Globulin Intravenous Market Size Forecast (2021-2026)
        12.3.1 Europe: Human Immune Globulin Intravenous Sales Forecast (2021-2026)
        12.3.2 Europe: Human Immune Globulin Intravenous Revenue Forecast (2021-2026)
        12.3.3 Europe: Human Immune Globulin Intravenous Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Human Immune Globulin Intravenous Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Human Immune Globulin Intravenous Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Human Immune Globulin Intravenous Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Human Immune Globulin Intravenous Market Size Forecast by Region (2021-2026)
    12.5 Latin America Human Immune Globulin Intravenous Market Size Forecast (2021-2026)
        12.5.1 Latin America: Human Immune Globulin Intravenous Sales Forecast (2021-2026)
        12.5.2 Latin America: Human Immune Globulin Intravenous Revenue Forecast (2021-2026)
        12.5.3 Latin America: Human Immune Globulin Intravenous Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Human Immune Globulin Intravenous Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Human Immune Globulin Intravenous Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Human Immune Globulin Intravenous Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Human Immune Globulin Intravenous Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Human Immune Globulin Intravenous Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Human Immune Globulin Intravenous Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Human Immune Globulin Intravenous Market Segments Table 2. Ranking of Global Top Human Immune Globulin Intravenous Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Human Immune Globulin Intravenous Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million) Table 4. Major Manufacturers of IVIg Liquid Table 5. Major Manufacturers of IVIg Powder Table 6. Global Human Immune Globulin Intravenous Market Size Growth Rate by Application 2020-2026 (MT) Table 7. Global Human Immune Globulin Intravenous Market Size by Region (MT) & (US$ Million): 2020 VS 2026 Table 8. Global Human Immune Globulin Intravenous Sales by Regions 2015-2020 (MT) Table 9. Global Human Immune Globulin Intravenous Sales Market Share by Regions (2015-2020) Table 10. Global Human Immune Globulin Intravenous Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Human Immune Globulin Intravenous Sales by Manufacturers (2015-2020) (MT) Table 12. Global Human Immune Globulin Intravenous Sales Share by Manufacturers (2015-2020) Table 13. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Human Immune Globulin Intravenous by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immune Globulin Intravenous as of 2019) Table 15. Human Immune Globulin Intravenous Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Human Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Human Immune Globulin Intravenous Price (2015-2020) (USD/Kg) Table 18. Human Immune Globulin Intravenous Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Human Immune Globulin Intravenous Product Type Table 20. Date of International Manufacturers Enter into Human Immune Globulin Intravenous Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 23. Global Human Immune Globulin Intravenous Sales Share by Type (2015-2020) Table 24. Global Human Immune Globulin Intravenous Revenue by Type (2015-2020) (US$ Million) Table 25. Global Human Immune Globulin Intravenous Revenue Share by Type (2015-2020) Table 26. Human Immune Globulin Intravenous Average Selling Price (ASP) by Type 2015-2020 (USD/Kg) Table 27. Global Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 28. Global Human Immune Globulin Intravenous Sales Share by Application (2015-2020) Table 29. North America Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 30. North America Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 31. North America Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 32. North America Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 33. North America Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 34. North America Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Table 35. North America Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 36. North America Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 37. Europe Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 38. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 39. Europe Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 41. Europe Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 42. Europe Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Table 43. Europe Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 44. Europe Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2015-2020) (MT) Table 46. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Human Immune Globulin Intravenous Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Human Immune Globulin Intravenous Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 50. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 52. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 53. Latin America Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 54. Latin America Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 57. Latin America Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 58. Latin America Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Table 59. Latin America Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 60. Latin America Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 62. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Human Immune Globulin Intravenous Sales by Type (2015-2020) (MT) Table 66. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Human Immune Globulin Intravenous Sales by Application (2015-2020) (MT) Table 68. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 69. Baxter Corporation Information Table 70. Baxter Description and Major Businesses Table 71. Baxter Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 72. Baxter Product Table 73. Baxter Recent Development Table 74. Grifols Corporation Information Table 75. Grifols Description and Major Businesses Table 76. Grifols Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 77. Grifols Product Table 78. Grifols Recent Development Table 79. CSL Corporation Information Table 80. CSL Description and Major Businesses Table 81. CSL Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 82. CSL Product Table 83. CSL Recent Development Table 84. Octapharma Corporation Information Table 85. Octapharma Description and Major Businesses Table 86. Octapharma Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 87. Octapharma Product Table 88. Octapharma Recent Development Table 89. Biotest Corporation Information Table 90. Biotest Description and Major Businesses Table 91. Biotest Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 92. Biotest Product Table 93. Biotest Recent Development Table 94. Kedrion Corporation Information Table 95. Kedrion Description and Major Businesses Table 96. Kedrion Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 97. Kedrion Product Table 98. Kedrion Recent Development Table 99. Hualan Bio Corporation Information Table 100. Hualan Bio Description and Major Businesses Table 101. Hualan Bio Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 102. Hualan Bio Product Table 103. Hualan Bio Recent Development Table 104. CNBG Corporation Information Table 105. CNBG Description and Major Businesses Table 106. CNBG Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 107. CNBG Product Table 108. CNBG Recent Development Table 109. Shanghai RAAS Corporation Information Table 110. Shanghai RAAS Description and Major Businesses Table 111. Shanghai RAAS Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 112. Shanghai RAAS Product Table 113. Shanghai RAAS Recent Development Table 114. CBPO Corporation Information Table 115. CBPO Description and Major Businesses Table 116. CBPO Human Immune Globulin Intravenous Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 117. CBPO Product Table 118. CBPO Recent Development Table 119. LFB Group Corporation Information Table 120. LFB Group Description and Major Businesses Table 121. LFB Group Human Immune Globulin Intravenous Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 122. LFB Group Product Table 123. LFB Group Recent Development Table 124. BPL Corporation Information Table 125. BPL Description and Major Businesses Table 126. BPL Human Immune Globulin Intravenous Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 127. BPL Product Table 128. BPL Recent Development Table 129. Sichuan Yuanda Shuyang Corporation Information Table 130. Sichuan Yuanda Shuyang Description and Major Businesses Table 131. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 132. Sichuan Yuanda Shuyang Product Table 133. Sichuan Yuanda Shuyang Recent Development Table 134. Global Human Immune Globulin Intravenous Sales Forecast by Regions (2021-2026) (MT) Table 135. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Regions (2021-2026) Table 136. Global Human Immune Globulin Intravenous Revenue Forecast by Regions (2021-2026) (US$ Million) Table 137. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Regions (2021-2026) Table 138. North America: Human Immune Globulin Intravenous Sales Forecast by Country (2021-2026) (MT) Table 139. North America: Human Immune Globulin Intravenous Revenue Forecast by Country (2021-2026) (US$ Million) Table 140. Europe: Human Immune Globulin Intravenous Sales Forecast by Country (2021-2026) (MT) Table 141. Europe: Human Immune Globulin Intravenous Revenue Forecast by Country (2021-2026) (US$ Million) Table 142. Asia Pacific: Human Immune Globulin Intravenous Sales Forecast by Region (2021-2026) (MT) Table 143. Asia Pacific: Human Immune Globulin Intravenous Revenue Forecast by Region (2021-2026) (US$ Million) Table 144. Latin America: Human Immune Globulin Intravenous Sales Forecast by Country (2021-2026) (MT) Table 145. Latin America: Human Immune Globulin Intravenous Revenue Forecast by Country (2021-2026) (US$ Million) Table 146. Middle East and Africa: Human Immune Globulin Intravenous Sales Forecast by Country (2021-2026) (MT) Table 147. Middle East and Africa: Human Immune Globulin Intravenous Revenue Forecast by Country (2021-2026) (US$ Million) Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 149. Key Challenges Table 150. Market Risks Table 151. Main Points Interviewed from Key Human Immune Globulin Intravenous Players Table 152. Human Immune Globulin Intravenous Customers List Table 153. Human Immune Globulin Intravenous Distributors List Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Human Immune Globulin Intravenous Product Picture Figure 2. Global Human Immune Globulin Intravenous Sales Market Share by Type in 2020 & 2026 Figure 3. IVIg Liquid Product Picture Figure 4. IVIg Powder Product Picture Figure 5. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2020 & 2026 Figure 6. Immunodeficiency Figure 7. Autoimmune Disease Figure 8. Acute Infection Figure 9. Human Immune Globulin Intravenous Report Years Considered Figure 10. Global Human Immune Globulin Intravenous Market Size 2015-2026 (US$ Million) Figure 11. Global Human Immune Globulin Intravenous Sales 2015-2026 (MT) Figure 12. Global Human Immune Globulin Intravenous Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Human Immune Globulin Intravenous Sales Market Share by Region (2015-2020) Figure 14. Global Human Immune Globulin Intravenous Sales Market Share by Region in 2019 Figure 15. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2015-2020) Figure 16. Global Human Immune Globulin Intravenous Revenue Market Share by Region in 2019 Figure 17. Global Human Immune Globulin Intravenous Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Human Immune Globulin Intravenous Revenue in 2019 Figure 19. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020) Figure 21. Global Human Immune Globulin Intravenous Sales Market Share by Type in 2019 Figure 22. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2015-2020) Figure 23. Global Human Immune Globulin Intravenous Revenue Market Share by Type in 2019 Figure 24. Global Human Immune Globulin Intravenous Market Share by Price Range (2015-2020) Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Figure 26. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2019 Figure 27. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2015-2020) Figure 28. Global Human Immune Globulin Intravenous Revenue Market Share by Application in 2019 Figure 29. North America Human Immune Globulin Intravenous Sales Growth Rate 2015-2020 (MT) Figure 30. North America Human Immune Globulin Intravenous Revenue Growth Rate 2015-2020 (US$ Million) Figure 31. North America Human Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 32. North America Human Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 33. U.S. Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 34. U.S. Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Canada Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 36. Canada Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. North America Human Immune Globulin Intravenous Market Share by Type in 2019 Figure 38. North America Human Immune Globulin Intravenous Market Share by Application in 2019 Figure 39. Europe Human Immune Globulin Intravenous Sales Growth Rate 2015-2020 (MT) Figure 40. Europe Human Immune Globulin Intravenous Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 42. Europe Human Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 43. Germany Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 44. Germany Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. France Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 46. France Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. U.K. Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 48. U.K. Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Italy Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 50. Italy Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Russia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 52. Russia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Europe Human Immune Globulin Intravenous Market Share by Type in 2019 Figure 54. Europe Human Immune Globulin Intravenous Market Share by Application in 2019 Figure 55. Asia Pacific Human Immune Globulin Intravenous Sales Growth Rate 2015-2020 (MT) Figure 56. Asia Pacific Human Immune Globulin Intravenous Revenue Growth Rate 2015-2020 (US$ Million) Figure 57. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region in 2019 Figure 58. Asia Pacific Human Immune Globulin Intravenous Revenue Market Share by Region in 2019 Figure 59. China Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 60. China Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Japan Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 62. Japan Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. South Korea Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 64. South Korea Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. India Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 66. India Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Australia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 68. Australia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Taiwan Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 70. Taiwan Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Indonesia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 72. Indonesia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Thailand Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 74. Thailand Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Malaysia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 76. Malaysia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Philippines Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 78. Philippines Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Vietnam Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 80. Vietnam Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Asia Pacific Human Immune Globulin Intravenous Market Share by Type in 2019 Figure 82. Asia Pacific Human Immune Globulin Intravenous Market Share by Application in 2019 Figure 83. Latin America Human Immune Globulin Intravenous Sales Growth Rate 2015-2020 (MT) Figure 84. Latin America Human Immune Globulin Intravenous Revenue Growth Rate 2015-2020 (US$ Million) Figure 85. Latin America Human Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 86. Latin America Human Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 87. Mexico Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 88. Mexico Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Brazil Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 90. Brazil Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Argentina Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 92. Argentina Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Latin America Human Immune Globulin Intravenous Market Share by Type in 2019 Figure 94. Latin America Human Immune Globulin Intravenous Market Share by Application in 2019 Figure 95. Middle East and Africa Human Immune Globulin Intravenous Sales Growth Rate 2015-2020 (MT) Figure 96. Middle East and Africa Human Immune Globulin Intravenous Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Human Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 99. Turkey Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 100. Turkey Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 102. Saudi Arabia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 104. U.A.E Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Middle East and Africa Human Immune Globulin Intravenous Market Share by Type in 2019 Figure 106. Middle East and Africa Human Immune Globulin Intravenous Market Share by Application in 2019 Figure 107. North America Human Immune Globulin Intravenous Sales Growth Rate Forecast (2021-2026) (MT) Figure 108. North America Human Immune Globulin Intravenous Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 109. Europe Human Immune Globulin Intravenous Sales Growth Rate Forecast (2021-2026) (MT) Figure 110. Europe Human Immune Globulin Intravenous Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 111. Asia Pacific Human Immune Globulin Intravenous Sales Growth Rate Forecast (2021-2026) (MT) Figure 112. Asia Pacific Human Immune Globulin Intravenous Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Latin America Human Immune Globulin Intravenous Sales Growth Rate Forecast (2021-2026) (MT) Figure 114. Latin America Human Immune Globulin Intravenous Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Middle East and Africa Human Immune Globulin Intravenous Sales Growth Rate Forecast (2021-2026) (MT) Figure 116. Middle East and Africa Human Immune Globulin Intravenous Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Porter's Five Forces Analysis Figure 118. Channels of Distribution Figure 119. Distributors Profiles Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Chemicals and Advanced Materials Reports

Turf Protection Flooring Rental Market - Growth, Trends, and Forecast to 2025

As per the credible estimates, turf protection flooring rental industry is predicted grow considerably through 2025. Surging investments towards infrastructural development along with rapid urbanization are bolstering the demand for natural as well a...

Softline Coating Market Size | Global Industry Growth Report, 2025

As per credible estimates, Softline coating market is poised to acquire commendable gains by the end of 2025. Softline coatings offer additional features such as breathability, heat stability, stain & soil repellence, anti-abrasion, anti-scratch,...

Scandium Metal Market Trends and Research Insights by 2025

According to trusted estimates, global scandium metal market is projected to expand with a CAGR of 3.4% during 2020-2025 to accrue USD 78 million by the end of study period. Growing use of scandium in solid oxide fuel cells, metallurgy, ceramics, ele...

Carbon Textile Reinforced Concrete Market Research Report 2025

As per credible estimates, carbon textile reinforced concrete industry is presumed to expand with 4.7% CAGR over the next five years to amass USD 26 million by the year 2025. Growing population and increasing infrastructural development have amplifie...

Pump in Lubrication Application Market Research Report 2025

Lubrication systems use pumps for directing lubricants from the reservoir to all the lubrication points of the machine. Rapid growth of automotive and construction industries is boosting the adoption of these systems. Lubricating pumps aid in extendi...

Other Reports by QY Research

Global and Japan Anti-Migraine Drugs Market Insights, Forecast to 2026

Anti-Migraine Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a ...

Global and Japan Hyperlipidemia Prescription Drugs Market Insights, Forecast to 2026

Hyperlipidemia Prescription Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hyperlipidemia Prescription Drugs market will be able to gain the upper hand ...

Global and China Anti-Hypertensive Drugs Market Insights, Forecast to 2026

Anti-Hypertensive Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the repo...

Global and United States Gaucher Disease Drugs Market Insights, Forecast to 2026

Gaucher Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease Drugs market will be able to gain the upper hand as they use the report a...

Global and China Ubiquitin Proteasome Market Size, Status and Forecast 2020-2026

Global Ubiquitin Proteasome Scope and Market Size Ubiquitin Proteasome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ubiquitin Proteasome market will be able to gain the upper hand as th...

Publisher: QY Research
Chat with us